Pseudobulbar Affect (PBA)
3 clinical trials · Condition
◉ Watch Pseudobulbar Affect (PBA)
| Record | Firm | Date |
|---|---|---|
| Safety, Tolerability and Effectiveness of Nuedexta in the Treatment of Pseudobulbar Affect (PBA) (NCT01799941) | Avanir Pharmaceuticals | 2013-02-01 |
| Nuedexta in the Treatment of Pseudobulbar Affect in Patients With Alzheimer's Disease (NCT01832350) | St. Joseph's Hospital and Medical Center, Phoenix | 2012-08-28 |
| Safety and Efficacy of AVP-923 in PBA Patients With ALS or MS (NCT00573443) | Avanir Pharmaceuticals | 2007-12-01 |
Track Pseudobulbar Affect (PBA) automatically
Every clearance here is in the API, with alerts when new ones post.